University of Tasmania
Browse

File(s) not publicly available

Preliminary report: role of peptide YY in defence against diarrhoea

journal contribution
posted on 2023-05-17, 08:03 authored by Playford, RJ, Domin, J, Beacham, J, Parmar, KB, Tatemoto, K, Bloom, SR, Calam, J
To investigate whether peptide YY (PYY) has a role in minimising fluid loss during diarrhoea, its effect on hypersecretion induced by vasoactive intestinal peptide (VIP) was studied in seven subjects with ileostomies. An isotonic electrolyte solution containing polyethylene glycol 4000 was infused directly into the duodenum and the effluent was collected for 40 min (baseline), then VIP was infused intravenously at 5 pmol.kg-1.min-1 for 500 min. PYY was infused intravenously at low doses (0·4 and 0·2 pmol.kg-1.min-1) for 100 min each during the continuous VIP infusion. Small-intestinal secretion was assessed by effluent weight and by polyethylene glycol dilution, which gave similar results. Plateau ileal output was 501 (SEM 33) ml/h during VIP infusion. PYY caused significant falls in secretion-to 404 (48) ml/h for the lower dose and to 323 (75) ml/h for the higher. It also prolonged small-bowel transit. These findings suggest that PYY is a natural inhibitor of diarrhoea and that its therapeutic potential merits investigation. © 1990.

History

Publication title

The Lancet

Volume

335

Issue

8705

Pagination

1555-1557

ISSN

0140-6736

Department/School

College Office - College of Health and Medicine

Publisher

Lancet Ltd

Place of publication

84 Theobalds Rd, London, England, Wc1X 8Rr

Repository Status

  • Restricted

Socio-economic Objectives

Clinical health not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC